Revvity, Inc. (LON:0KHE)
94.56
-7.83 (-7.64%)
Feb 12, 2026, 4:50 PM GMT
Revvity Market Cap
Revvity has a market cap or net worth of 8.4 billion as of February 12, 2026. Its market cap has decreased by -31.65% in one year.
Market Cap
8.40B
Enterprise Value
10.20B
Revenue
2.12B
Ranking
n/a
PE Ratio
46.97
Stock Price
94.56
Market Cap Chart
Since January 2, 1968, Revvity's market cap has increased from 287.00M to 8.40B, an increase of 2,827.20%. That is a compound annual growth rate of 5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 8.40B | 3.08% |
| Dec 31, 2025 | 8.15B | -24.88% |
| Dec 31, 2024 | 10.85B | 2.45% |
| Dec 29, 2023 | 10.59B | -27.96% |
| Dec 30, 2022 | 14.70B | -21.55% |
| Dec 31, 2021 | 18.74B | 59.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.75B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.40B |
| Hikma Pharmaceuticals | 3.41B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |